CA2472371A1 - Methodes et systemes pour determiner et reguler les reponses glycemiques - Google Patents
Methodes et systemes pour determiner et reguler les reponses glycemiques Download PDFInfo
- Publication number
- CA2472371A1 CA2472371A1 CA002472371A CA2472371A CA2472371A1 CA 2472371 A1 CA2472371 A1 CA 2472371A1 CA 002472371 A CA002472371 A CA 002472371A CA 2472371 A CA2472371 A CA 2472371A CA 2472371 A1 CA2472371 A1 CA 2472371A1
- Authority
- CA
- Canada
- Prior art keywords
- comestible
- glycemic
- standard
- load
- dietary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002641 glycemic effect Effects 0.000 title claims abstract 139
- 238000000034 method Methods 0.000 title claims abstract 68
- 235000005911 diet Nutrition 0.000 claims abstract 55
- 230000000378 dietary effect Effects 0.000 claims abstract 49
- 230000002596 correlated effect Effects 0.000 claims abstract 9
- 235000012794 white bread Nutrition 0.000 claims 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 17
- 239000008103 glucose Substances 0.000 claims 17
- 150000001720 carbohydrates Chemical class 0.000 claims 14
- 239000008280 blood Substances 0.000 claims 12
- 210000004369 blood Anatomy 0.000 claims 12
- 230000037213 diet Effects 0.000 claims 6
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 208000013016 Hypoglycemia Diseases 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 238000004590 computer program Methods 0.000 claims 2
- 230000001276 controlling effect Effects 0.000 claims 2
- 235000018823 dietary intake Nutrition 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 201000008980 hyperinsulinism Diseases 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 230000002218 hypoglycaemic effect Effects 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 108010023302 HDL Cholesterol Proteins 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 235000021004 dietary regimen Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing And Processing Devices For Dough (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
La présente invention concerne une méthode destinée à déterminer une charge glycémique équivalente de produit comestible standard d'un produit comestible alimentaire. Cette méthode consiste (a) à établir un indice de réponse glycémique fiable pour un produit comestible standard, cet indice établissant une corrélation entre la réponse glycémique et la charge glycémique, (b) à déterminer la réponse glycémique produite par un produit comestible alimentaire, et (c) à identifier la charge glycémique du produit comestible standard à partir de l'indice en corrélation avec la réponse glycémique du produit comestible alimentaire.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/030216 WO2005040752A2 (fr) | 2002-08-28 | 2003-09-24 | Methodes et systemes permettant de determiner et de reguler les reponses glycemiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2472371A1 true CA2472371A1 (fr) | 2005-03-24 |
| CA2472371C CA2472371C (fr) | 2010-12-14 |
Family
ID=34421188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2472371A Expired - Lifetime CA2472371C (fr) | 2003-09-24 | 2003-09-24 | Methodes et systemes pour determiner et reguler les reponses glycemiques |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1613179A4 (fr) |
| JP (1) | JP2006519035A (fr) |
| AU (1) | AU2003278921A1 (fr) |
| CA (1) | CA2472371C (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322093B1 (fr) * | 2008-07-31 | 2018-01-10 | Sysmex Corporation | Procédé de dosage d'un composant in vivo et appareil et élément de collecte pour le dosage d'un composant in vivo |
| WO2013038826A1 (fr) * | 2011-09-13 | 2013-03-21 | テルモ株式会社 | Système de notification |
| JP6084568B2 (ja) * | 2011-09-27 | 2017-02-22 | テルモ株式会社 | アナライトモニタシステム |
| JP5815362B2 (ja) * | 2011-10-17 | 2015-11-17 | シスメックス株式会社 | 耐糖能分析装置、耐糖能分析システム及びコンピュータプログラム |
| WO2023243395A1 (fr) * | 2022-06-15 | 2023-12-21 | 株式会社島津製作所 | Procédé d'estimation, programme d'estimation, système d'estimation, procédé de détermination et marqueur d'estimation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020132279A1 (en) * | 2000-05-30 | 2002-09-19 | Linda Hockersmith | Formula to manipulate blood glucose via the calculated ingestion of carbohydrate |
| EP1309250A2 (fr) * | 2000-08-08 | 2003-05-14 | Advanced Functional Foods International, Inc. | Complement alimentaire destine a la gestion du poids |
-
2003
- 2003-09-24 AU AU2003278921A patent/AU2003278921A1/en not_active Abandoned
- 2003-09-24 EP EP03770436A patent/EP1613179A4/fr not_active Withdrawn
- 2003-09-24 CA CA2472371A patent/CA2472371C/fr not_active Expired - Lifetime
- 2003-09-24 JP JP2005509913A patent/JP2006519035A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003278921A1 (en) | 2005-05-11 |
| CA2472371C (fr) | 2010-12-14 |
| EP1613179A2 (fr) | 2006-01-11 |
| EP1613179A4 (fr) | 2006-05-17 |
| JP2006519035A (ja) | 2006-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McKeown et al. | Dietary and nondietary determinants of vitamin K biochemical measures in men and women | |
| Promislow et al. | Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study | |
| O’Byrne et al. | Low fat-monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles | |
| Haas et al. | Iron-biofortified rice improves the iron stores of nonanemic Filipino women | |
| Ingram et al. | Dietary restriction and aging: the initiation of a primate study | |
| Davies et al. | Calcium intake and body weight | |
| Allen et al. | Lack of hemoglobin response to iron supplementation in anemic Mexican preschoolers with multiple micronutrient deficiencies | |
| Miura et al. | Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: the Chicago Western Electric Study | |
| Millen et al. | Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study | |
| Pepersack et al. | Prevalence of zinc deficiency and its clinical relevance among hospitalised elderly | |
| Tatala et al. | Low dietary iron availability is a major cause of anemia: a nutrition survey in the Lindi District of Tanzania | |
| Mayfield et al. | Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients | |
| Jiao et al. | Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study | |
| Perignon et al. | The bioavailability of iron, zinc, protein and vitamin A is highly variable in French individual diets: Impact on nutrient inadequacy assessment and relation with the animal-to-plant ratio of diets | |
| Thomas et al. | Erythrocyte metallothionein response to dietary zinc in humans | |
| Zhang et al. | A prospective study of intakes of zinc and heme iron and colorectal cancer risk in men and women | |
| Heseker et al. | Requirement and supply of vitamin C, E and f-carotene for elderly men | |
| Huang et al. | Vitamin B-6 requirement and status assessment of young women fed a high-protein diet with various levels of vitamin B-6 | |
| Metwally et al. | Insulin pump dosing strategies for meals varying in fat, protein or glycaemic index or grazing-style meals in type 1 diabetes: A systematic review | |
| Gibson et al. | A case for reducing salt in processed foods | |
| Magee et al. | Contribution of dietary protein and inorganic sulfur to urinary sulfate: toward a biomarker of inorganic sulfur intake | |
| CA2472371A1 (fr) | Methodes et systemes pour determiner et reguler les reponses glycemiques | |
| Custódio das Dôres et al. | Relationship between diet and anticoagulant response to warfarin: a factor analysis | |
| EP3468670A1 (fr) | Procédés d'induction de perte de poids, de traitement de l'obésité et de prévention de la prise de poids | |
| Krone et al. | Ascorbic acid, glycation, glycohemoglobin and aging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20230925 |